First patient enrolled in 60 degrees pharmaceuticals clinical trial of tafenoquine for babesiosis at tufts medical center; first and only study of its kind

60 degrees pharmaceuticals enrolls first patient in a clinical study at tufts to assess safety and efficacy of tafenoquine in treating acute babesiosis.
SXTP Ratings Summary
SXTP Quant Ranking